Join
Live feed
·
PRReleasevia Quantisnow
GlucoTrack Inc. logo

Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration

ByQuantisnow·Wall Street's wire, on your screen.
GCTK· GlucoTrack Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GCTK (GlucoTrack Inc.) and more on Quantisnow.